Deltec 21-4155-24Recalls & reported problems
Icu Medical, Inc. · Class 2 · Implant
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 13
- Deaths reported
- 0
- Injuries reported
- 9
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 13 adverse event reports that list this exact device (DI 10610586012594), received between Jan 22, 2020 and Jul 14, 2025 — classified as 9 injuries, 4 malfunctions.
The most frequently reported specific device problem is “Fluid/Blood Leak” (3 reports).
1 FDA recall record name this device's identifier, 1 still open.
10 other recalls cover devices cleared under the same FDA submission (K994216); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Recalls naming this device
- Feb 13, 2025Open, Classified
The plastic port housing and port reservoir of the ProPort Plastic Implantable Ports may separate because of a manufacturing defect.
Z-1281-2025 · Root cause: Process control · FDA record ↗
Most reported problems
Device problems
- Fluid/Blood Leak3
- Insufficient Device Problem Information3
- Leak/Splash3
- Adverse Event Without Identified Device or Use Problem1
- Break1
- Connection Problem1
- Decoupling1
- Disconnection1
Patient problems
- Extravasation4
- Infiltration into Tissue3
- No Consequences Or Impact To Patient3
- Swelling/ Edema3
- No Clinical Signs, Symptoms or Conditions2
- Pain2
- Erythema1
- Patient Problem/Medical Problem1
Recent adverse event reports
The 13 most recent of 13 reports, in the reporter's own words as published by the FDA.
InjuryJul 14, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A PRODUCT LIABILITY LAWSUIT WAS RECEIVED THROUGH A WATCH SERVICE. THE LAWSUIT ALLEGES THE FOLLOWING: ON OR ABOUT (B)(6) 2023, THE PATIENT'S PROPORT, 21-4155-24, LOT NUMBER 4307473 WAS EXPLANTED DUE TO INFECTION AND CHEST WALL ABSCESS. THIS DEVICE WAS IMPLANTED FOR THE PURPOSE OF ADMINISTERING CHEMOTHERAPY AND OTHER TREATMENTS ASSOCIATED WITH TESTICULAR SEMINOMA AND LYMPHOMA ON OR ABOUT (B)(6) 2023.
Patient problems: Skin Inflammation/ Irritation
MAUDE report 22498966 ↗InjuryMay 1, 2025Fluid/Blood Leak; Fluid/Blood Leak
IT WAS REPORTED THAT THE PORT LEAKED CAUSING SHOULDER PAIN. THERE WAS PATIENT INVOLVEMENT, AS THE PATIENT WOKE UP FROM SLEEP WITH PAIN TO THE LEFT SHOULDER AND NOTICED THE DRESSING AROUND THE PORT WAS LEAKING. THE PATIENT REPORTED TO THE EMERGENCY ROOM (ER) AND HAD EXPERIENCED SLIGHT RAISED EDEMA AROUND THE PORT. THERE WAS A MEDICAL INTERVENTION, CHEMOTHERAPY INFUSION WAS STOPPED, REMOVED THE NEEDLE FROM THE PORT, AND FLUSHED THE PORT. THE OUTCOME OF THE EVENT WAS THE PATIENT SHOWED UP TO THE ER, FOUR DAYS AFTER, WITH LEFT SHOULDER AND ARM PAIN. PAIN WORSE WITH MOVEMENT AND DEEP BREATHS. THE PORT WAS REMOVED BY THE SURGEON. PATIENT DATE OF BIRTH IS (B)(6) 1997. THE DATE OF EVENT WAS ON (B)(6) 2025 AND (B)(6) 2025.
Patient problems: Pain; Swelling/ Edema
MAUDE report 21942962 ↗InjuryMay 1, 2025Fluid/Blood Leak; Fluid/Blood Leak
IT WAS REPORTED THAT THE PORT LEAKED CAUSING SHOULDER PAIN. THERE WAS PATIENT INVOLVEMENT, AS THE PATIENT WOKE UP FROM SLEEP WITH PAIN TO THE LEFT SHOULDER AND NOTICED THE DRESSING AROUND THE PORT WAS LEAKING. THE PATIENT REPORTED TO THE EMERGENCY ROOM (ER) AND HAD EXPERIENCED SLIGHT RAISED EDEMA AROUND THE PORT. THERE WAS A MEDICAL INTERVENTION, CHEMOTHERAPY INFUSION WAS STOPPED, REMOVED THE NEEDLE FROM THE PORT, AND FLUSHED THE PORT. THE OUTCOME OF THE EVENT WAS THE PATIENT SHOWED UP TO THE ER, FOUR DAYS AFTER, WITH LEFT SHOULDER AND ARM PAIN. PAIN WORSE WITH MOVEMENT AND DEEP BREATHS. THE PORT WAS REMOVED BY THE SURGEON. PATIENT DATE OF BIRTH IS (B)(6) 1997. THE DATE OF EVENT WAS ON 3-APR-2025 AND 7-APR-2025.
Patient problems: Pain; Swelling/ Edema
MAUDE report 21942927 ↗MalfunctionApr 23, 2025Fluid/Blood Leak; Fluid/Blood Leak
IT WAS REPORTED THAT THE PORT LEAKED. AS THE PORT WAS DE-ACCESSED SWELLING WAS NOTED IN THE AREA ABOVE THE PORT NEAR THE PATIENT¿S LEFT SHOULDER AND AN ERYTHEMATOUS HALO WAS NOTED ABOVE THE PORT. THERE WAS NO MEDICAL INTERVENTION REQUIRED. THE SWELLING AND REDNESS AROUND THE PORT RESOLVED.
Patient problems: Erythema; Swelling/ Edema
MAUDE report 21892707 ↗MalfunctionOct 7, 2024Break; Break
IT WAS REPORTED THAT THE FAULTY END OF CATHETER, HOSPITAL STATES THAT THE DEFECT AT THE END OF CATHETER WAS VISIBLE UPON OPENING THE BOX. THERE WAS NO PATIENT INVOLVEMENT, AND NO PATIENT HARM/ADVERSE EVENT REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20390661 ↗MalfunctionAug 31, 2022Disconnection; Disconnection
IT WAS REPORTED THAT DEVICE WAS INSTALLED IN PATIENT ON (B)(6) 2019. ON (B)(6) 2019, PROBLEMS WERE DETECTED AFTER THE DEVICE WAS PUNCTURED, DETECTING FILTRATION. CHEST X-RAY PERFORMED. UPON REMOVAL OF DEVICE, IT WAS FOUND THAT THE BASE WAS NOT ATTACHED TO THE REST OF THE RESERVOIR. A NEW DEVICE WAS INSTALLED. NO PATIENT INJURY WAS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15327571 ↗InjuryFeb 21, 2020Leak/Splash; Leak/Splash
INFORMATION WAS RECEIVED THAT UPON ADMINISTRATION OF CHEMOTHERAPY THROUGH A SMITHS MEDICAL DELTEC IMPLANTABLE PORT, FILTRATION AND EXTRAVASATION OCCURRED. A PERIPHERAL ROUTE WAS INSTALLED AS A RESULT TO ADMINISTER PENDING CHEMOTHERAPY TREATMENT.
Patient problems: Extravasation; Infiltration into Tissue
MAUDE report 9740028 ↗InjuryFeb 19, 2020Leak/Splash; Leak/Splash
INFORMATION WAS RECEIVED INDICATING THAT A PATIENT RECEIVING CHEMOTHERAPY THROUGH A SMITHS MEDICAL DELTEC® PROPORT PORTS IMPLANTABLE ACCESS SYSTEM WAS NOTED TO HAVE EXTRAVASATION. WITHDRAWAL WAS EFFECTIVELY PERFORMED TO VERIFY THAT STRUCTURAL FAILURE OCCURRED AT THE LEVEL OF THE UNION AT THE BASE OF THE RESERVOIR AND THAT IT EASILY UNCLOGS. THE PORT WAS LEFT IN PLACE AND CHEMO HAS BEEN CONTINUED VIA PERIPHERAL IV ROUTE. THERE WERE NO FURTHER REPORTED ADVERSE EFFECTS.
Patient problems: Extravasation; Infiltration into Tissue
MAUDE report 9730096 ↗InjuryFeb 19, 2020Leak/Splash; Leak/Splash
INFORMATION WAS RECEIVED INDICATING THAT A PATIENT RECEIVING CHEMOTHERAPY THROUGH A SMITHS MEDICAL DELTEC® PROPORT PORTS IMPLANTABLE ACCESS SYSTEM WAS NOTED TO HAVE INFILTRATION AND LEAKAGE INTO THEIR TISSUE. SUBSEQUENTLY, THE PORT WAS EXPLANTED AND DISCARDED WITH NO FURTHER ADVERSE EFFECTS.
Patient problems: Extravasation; Infiltration into Tissue
MAUDE report 9730095 ↗InjuryFeb 19, 2020Decoupling; Connection Problem; Decoupling; Connection Problem
IT WAS REPORTED THAT UPON ADMINISTRATION OF THE CHEMOTHERAPY, FILTRATION AND EXTRAVASATION (DAMAGE TO THE TISSUE) OCCURRED. THE OPERATOR SUSPECTED THAT THERE WAS A STRUCTURAL FAILURE FORM THE BASE OF THE RESERVOIR (EASILY DECOUPLES). THE OPERATOR STOPPED USING THE CATHETERS, AND PERIPHERAL ROUTES WERE ADMINISTERED IN ORDER TO DELIVER THE REMAINING VOLUME OF TREATMENT. THE PREVIOUS CATHETERS WERE LEFT IN PLACE HOWEVER. NO FURTHER COMPLICATIONS WERE REPORTED IN RELATION TO THIS EVENT.
Patient problems: Extravasation; Patient Problem/Medical Problem
MAUDE report 9728783 ↗MalfunctionJan 22, 2020Insufficient Device Problem Information; Insufficient Device Problem Information
INFORMATION WAS RECEIVED INDICATING THAT ONE MONTH FOLLOWING IMPLANT OF A SMITHS MEDICAL DELTEC® PROPORT PORT, IT WAS FOUND IN POOR CONDITION. THE PATIENT WENT TO THE OPERATING ROOM TO VERIFY PORT FUNCTION UNDER X-RAY. CHEMOTHERAPY WAS DISCONTINUED AND THE PORT WAS EXPLANTED. NO FURTHER ADVERSE EFFECTS WERE REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9618351 ↗InjuryJan 22, 2020Insufficient Device Problem Information; Insufficient Device Problem Information
INFORMATION WAS RECEIVED INDICATING THAT 14 WEEKS FOLLOWING IMPLANT OF A SMITHS MEDICAL DELTEC® PROPORT PORT, IT WAS FOUND IN POOR CONDITION. THE PATIENT WENT TO THE OPERATING ROOM TO VERIFY PORT FUNCTION UNDER X-RAY. CHEMOTHERAPY WAS DISCONTINUED AND THE PORT WAS EXPLANTED. NO FURTHER ADVERSE EFFECTS WERE REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9618350 ↗InjuryJan 22, 2020Insufficient Device Problem Information; Insufficient Device Problem Information
INFORMATION WAS RECEIVED INDICATING THAT FOUR MONTHS FOLLOWING IMPLANT OF A SMITHS MEDICAL DELTEC® PROPORT PORT, IT WAS FOUND IN POOR CONDITION. THE PATIENT WENT TO THE OPERATING ROOM TO VERIFY PORT FUNCTION UNDER X-RAY. CHEMOTHERAPY WAS DISCONTINUED AND THE PORT WAS EXPLANTED. NO FURTHER ADVERSE EFFECTS WERE REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9618349 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K994216. One submission often covers many models, so check the product and lot details in each record.
- Z-1282-2025 · Feb 13, 2025 · Open, Classifiedsmiths medical ProPort Plastic Venous Access System, Pre-assembled with PolyFlow Polyurethane Catheter, 2.6mm (7.8Fr) O.D. x 1.6mm I.D., 8.6Fr Introducer, REF 21-4165-24
- Z-1280-2025 · Feb 13, 2025 · Open, Classifiedsmiths medical ProPort Plastic Venous Access System, PolyFlow Polyurethane Catheter, 1.9mm (5.8Fr) O.D. x 1.0mm I.D., 6Fr Introducer, REF 21-4153-24
- Z-1287-2025 · Feb 13, 2025 · Open, Classifiedsmiths medical ProPort Low Profile Plastic Venous Access System, PolyFlow Polyurethane Catheter, 1.9mm (5.8Fr) O.D. x 1.0mm., 6Fr Introducer, REF 21-4183-24
- Z-1283-2025 · Feb 13, 2025 · Open, Classifiedsmiths medical ProPort Plastic Venous Access System, PolyFlow Catheter, 2.6 (7.8Fr) O.D. x 1.6mm I.D., 8.5Fr Introducer, REF 21-4171-24
- Z-1288-2025 · Feb 13, 2025 · Open, Classifiedsmiths medical ProPort Low Profile Plastic Venous Access System, Silicone Catheter, 2.8mm (8.4Fr) O.D. x 1.0mm I.D., 9Fr Introducer, REF 21-4187-24
- Z-0871-04 · Mar 29, 2004 · TerminatedProPort Plastic Venous Access System, with PolyFlow Polyurethane Catheter, 2.6mm O.D. x 1.6mm I.D., 8.5 French Introducer Set, REF 21-4155-24
- Z-0873-04 · Mar 29, 2004 · TerminatedProPort Low Profile Plastic Venous Access System, with PolyFlow Polyurethane Catheter, 2.6mm O.D. x 1.6mm I.D., 8.5 French Introducer Set, REF 21-4171-24
- Z-0872-04 · Mar 29, 2004 · TerminatedProPort Plastic Venous Access System, Pre-assembled with PolyFlow Polyurethane Catheter, 2.6mm O.D. x 1.6mm I.D., 8.5 French Introducer Set, REF 21-4165-24
- Z-0874-04 · Mar 29, 2004 · TerminatedProPort Low Profile Plastic Venous Access System, with PolyFlow Polyurethane Catheter, 1.9mm O.D. x 1.0mm I.D., 6 French Introducer Set, REF 21-4183-24
- Z-0875-04 · Mar 29, 2004 · TerminatedPort-A-Cath P.A.S. Port T2 Titanium Venous Access System, with PolyFlow Polyurethane Catheter, 1.9mm O.D. x 1.0mm I.D., 6 French Introducer Set, REF 21-4573-24
Other PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices
- PowerPort M.R.I., Groshong 9808560Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR3 deaths834 reports
- PowerPort ClearVUE 1608062Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR18 deaths571 reports
- PowerPort ClearVUE 5608062Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR31 deaths542 reports
- PowerPort M.R.I., ChronoFlex 1808000Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR19 deaths513 reports
- PowerPort M.R.I., ChronoFlex 1808060Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR1 recall15 deaths383 reports
- PowerPort M.R.I., Groshong 1808560Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR10 deaths304 reports
- PowerPort M.R.I., ChronoFlex 1829500Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR6 deaths197 reports
- BardPort M.R.I. 0602680Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR2 deaths179 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.